These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 22675664)

  • 1. Generating β cells from stem cells-the story so far.
    Hebrok M
    Cold Spring Harb Perspect Med; 2012 Jun; 2(6):a007674. PubMed ID: 22675664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of beta cells from human pluripotent stem cells: Potential for regenerative medicine.
    Nostro MC; Keller G
    Semin Cell Dev Biol; 2012 Aug; 23(6):701-10. PubMed ID: 22750147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From substitution of insulin to replacement of insulin producing cells: New therapeutic opportunities from research on pancreas development and stem cell differentiation.
    Zulewski H
    Best Pract Res Clin Endocrinol Metab; 2015 Dec; 29(6):815-20. PubMed ID: 26696511
    [No Abstract]   [Full Text] [Related]  

  • 4. Advances in the Generation of Functional β-cells from Induced Pluripotent Stem Cells As a Cure for Diabetes Mellitus.
    Kalra K; Chandrabose ST; Ramasamy TS; Kasim NHBA
    Curr Drug Targets; 2018; 19(13):1463-1477. PubMed ID: 29874998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of new islets from stem cells.
    Roche E; Soria B
    Cell Biochem Biophys; 2004; 40(3 Suppl):113-24. PubMed ID: 15289648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathways to new beta cells.
    Zhou Q; Melton DA
    Cold Spring Harb Symp Quant Biol; 2008; 73():175-81. PubMed ID: 19478324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minireview: beta-cell replacement therapy for diabetes in the 21st century: manipulation of cell fate by directed differentiation.
    Yechoor V; Chan L
    Mol Endocrinol; 2010 Aug; 24(8):1501-11. PubMed ID: 20219891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation and transplantation of functional pancreatic beta cells generated from induced pluripotent stem cells derived from a type 1 diabetes mouse model.
    Jeon K; Lim H; Kim JH; Thuan NV; Park SH; Lim YM; Choi HY; Lee ER; Kim JH; Lee MS; Cho SG
    Stem Cells Dev; 2012 Sep; 21(14):2642-55. PubMed ID: 22512788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cells to pancreatic beta-cells: new sources for diabetes cell therapy.
    Guo T; Hebrok M
    Endocr Rev; 2009 May; 30(3):214-27. PubMed ID: 19389995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-producing cells derived from stem cells: recent progress and future directions.
    Santana A; Enseñat-Waser R; Arribas MI; Reig JA; Roche E
    J Cell Mol Med; 2006; 10(4):866-83. PubMed ID: 17125591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes mellitus: a potential target for stem cell therapy.
    Burns CJ; Persaud SJ; Jones PM
    Curr Stem Cell Res Ther; 2006 May; 1(2):255-66. PubMed ID: 18220871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-producing cells derived from stem/progenitor cells: therapeutic implications for diabetes mellitus.
    Hori Y
    Med Mol Morphol; 2009 Dec; 42(4):195-200. PubMed ID: 20033363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell transplantation therapy for diabetes mellitus: endocrine pancreas and adipocyte.
    Fujikura J; Hosoda K; Nakao K
    Endocr J; 2013; 60(6):697-708. PubMed ID: 23719783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Present and future cell therapies for pancreatic beta cell replenishment.
    Domínguez-Bendala J; Ricordi C
    World J Gastroenterol; 2012 Dec; 18(47):6876-84. PubMed ID: 23322984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of human pluripotent stem cells into β-cells: Potential and challenges.
    Quiskamp N; Bruin JE; Kieffer TJ
    Best Pract Res Clin Endocrinol Metab; 2015 Dec; 29(6):833-47. PubMed ID: 26696513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concise review: pluripotent stem cell-based regenerative applications for failing β-cell function.
    Holditch SJ; Terzic A; Ikeda Y
    Stem Cells Transl Med; 2014 May; 3(5):653-61. PubMed ID: 24646490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Embryonic stem cell therapy for diabetes mellitus.
    Docherty K; Bernardo AS; Vallier L
    Semin Cell Dev Biol; 2007 Dec; 18(6):827-38. PubMed ID: 17959396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scalable production of pancreatic islet progenitors for diabetes cell therapies.
    Lock LT; Tzanakakis ES
    Med J Malaysia; 2008 Jul; 63 Suppl A():5-6. PubMed ID: 19024957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cell sources to treat diabetes.
    Furth ME; Atala A
    J Cell Biochem; 2009 Mar; 106(4):507-11. PubMed ID: 19130494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concise review: pancreas regeneration: recent advances and perspectives.
    Lysy PA; Weir GC; Bonner-Weir S
    Stem Cells Transl Med; 2012 Feb; 1(2):150-9. PubMed ID: 23197762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.